Russian Experience of Bosutinib Use in Chronic Myeloid Leukemia Patients in Routine Clinical Practice

被引：0
|
作者：
Shuvaev, Vasily [1 ]
Vinogradova, Olga [2 ,3 ,4 ]
Martynkevich, Irina [1 ]
Natalya, Novitskaya [2 ]
Fominykh, Mikhail [5 ]
Tsareva, Svetlana [6 ]
Shikhbabaeva, Dzhariyat [2 ]
Pankrashkina, Maria [2 ,3 ]
Chernikov, Mikhail [2 ]
Sharkunov, Nikolay [2 ]
Zotova, Irina [5 ]
Udaleva, Vera [5 ]
Motyko, Ekaterina [5 ]
Voloshin, Sergei [1 ,7 ,8 ]
机构：
[1] Fed Med Biol Agcy, Russian Sci Res Inst Hematol & Transfusiol, Fed State Budget Inst, St Petersburg, Russia
[2] Botkin City Clin Hosp, Hematol Moscow City Ctr, Moscow, Russia
[3] Dmitry Rogachev Natl Res Ctr Pediat Hematol Oncol, Moscow, Russia
[4] Pirogov Russian Natl Res Med Univ, Moscow, Russia
[5] Russian Res Inst Hematol & Transfusiol, St Petersburg, Russia
[6] Botkin City Hosp, Hematol Moscow City Ctr, Moscow, Russia
[7] Mil Med Acad, St Petersburg, Russia
[8] North Western State Med Univ, St Petersburg, Russia
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-114164
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5446
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Safety and Efficacy of Bosutinib in Fourth Line Therapy of Chronic Myeloid Leukemia Patients
    Garcia-Gutierrez, Valentin
    Milojkovic, Dragana
    Martin Mateos, Maria Luisa
    Claudiani, Simone
    Boque, Concepcion
    Felipe Casado, Luis
    Gonzalez, Gloria
    Jimenez, Antonio
    Martinez Trillos, Alejandra
    Mata Vazquez, Isabel
    Ramirez Payer, Angel
    Alvarez Larran, Alberto
    Amutio Diez, Elena
    Barez Garcia, Abelardo
    Bautista Carrascosa, Guiomar
    Bobillo Varela, Sabela
    Cuevas Ruiz, Beatriz
    Fernandez Fernandez, Ma Angeles
    Garcia Garay, Maria del Carmen
    Giraldo, Pilar
    Guinea de Castro, Jose Maria
    De Las Heras Rodriguez, Natalia
    Hernanz Soler, Nuria
    Iglesias Perez, Ana
    Lopez Lorenzo, Jose Luis
    Marti Tutusaus, Josep Maria
    Omar Vallansot, Rolando
    Ortega Rivas, Fernando
    Manuel Puerta, Jose
    Ramirez Sanchez, Maria Jose
    Romero Picos, Esperanza
    Romo Collada, Mario Andres
    Rosell Mas, Ana
    Saavedra Gerosa, Silvana
    Sebrango Sadia, Ana
    Tallon Perez, Jose
    Valencia, Sandra
    Luis Steegmann, Juan
    BLOOD, 2015, 126 (23)
  • [22] Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice
    Banerji, Versha
    Aw, Andrew
    Laferriere, Nicole
    Abdel-Samad, Nizar
    Peters, Anthea
    Johnson, Nathalie A.
    Bernard, Marie-Pierre
    Gopalakrishnan, Sathish
    Bull, Sarah-Jane
    Fournier, Pierre-Andre
    Klil-Drori, Adi J.
    Hay, Annette E.
    Robinson, Sue
    Owen, Carolyn
    LEUKEMIA & LYMPHOMA, 2024, 65 (05) : 609 - 617
  • [23] Atypical Chronic Myeloid Leukemia Challenge in Russian Hematology Practice
    Shuvaev, Vasily
    Krutikova, Karina
    Menshakova, Svetlana
    Kalinova, Natalya
    Martynkevich, Irina
    Polushkina, Lyubov
    Belyakova, Elena
    Krivolapov, Yury
    Voloshin, Sergei
    BLOOD, 2018, 132
  • [24] Comprehensive Genomic Profiling of Chronic Myelomonocytic Leukemia in Routine Clinical Practice - MSKCC Experience
    Pal, Prodipto
    Dogan, Ahmet
    Arcila, Maria
    Rampal, Raaju
    Wang, Lu
    Chiu, April
    MODERN PATHOLOGY, 2015, 28 : 371A - 371A
  • [25] Comprehensive Genomic Profiling of Chronic Myelomonocytic Leukemia in Routine Clinical Practice - MSKCC Experience
    Pal, Prodipto
    Dogan, Ahmet
    Arcila, Maria
    Rampal, Raajit
    Wang, Lu
    Chiu, April
    LABORATORY INVESTIGATION, 2015, 95 : 371A - 371A
  • [26] CLINICAL AND PROGNOSTIC VALUE OF FLT3 MUTATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS IN ROUTINE CLINICAL PRACTICE - SINGLE CENTER EXPERIENCE
    Radzhabova, A.
    Voloshin, S.
    Martynkevich, I.
    Shuvaev, V.
    Ivanova, M.
    Motyko, E.
    Cybakova, N.
    Polushkina, L.
    Shikhbabaeva, D.
    Potikhonova, N.
    Tyranova, S.
    Zenina, M.
    Kudryashova, S.
    Chechetkin, A.
    HAEMATOLOGICA, 2017, 102 : 678 - 678
  • [27] Erratum to: Pharmacokinetic–pharmacodynamic relationship of bosutinib in patients with chronic-phase chronic myeloid leukemia
    Poe-Hirr Hsyu
    Diane R. Mould
    Richard N. Upton
    Michael Amantea
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1105 - 1106
  • [28] Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice
    Giovanni Caocci
    Olga Mulas
    Elisabetta Abruzzese
    Alessandra Iurlo
    Mario Annunziata
    Ester Maria Orlandi
    Sara Galimberti
    Gianni Binotto
    Nicola Sgherza
    Luigia Luciano
    Bruno Martino
    Antonella Russo Rossi
    Massimiliano Bonifacio
    Claudio Fozza
    Malgorzata Monika Trawinska
    Daniele Cattaneo
    Chiara Elena
    Claudia Baratè
    Fiorenza De Gregorio
    Matteo Molica
    Giorgio La Nasa
    Robin Foà
    Massimo Breccia
    Annals of Hematology, 2019, 98 : 1885 - 1890
  • [29] Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic-phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY
    Hehlmann, Ruediger
    Cortes, Jorge E.
    Zyczynski, Teresa
    Gambacorti-Passerini, Carlo
    Goldberg, Stuart L.
    Mauro, Michael J.
    Michallet, Mauricette
    Simonsson, Bengt
    Williams, Loretta A.
    Gajavelli, Srikanth
    DeGutis, Irene
    Sen, Ginny P.
    Paquette, Ron L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (01) : 46 - 54
  • [30] CLINICAL ASPECTS OF NILOTINIB USE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE
    Gusarova, G. A.
    Turkina, A. G.
    Kolosheinova, T. I.
    Vakhrusheva, M. V.
    Chelysheva, E. Yu.
    Zakharova, E. S.
    Kuznetsov, S. V.
    Nemchenko, I. S.
    Sokolova, M. A.
    Goryacheva, S. R.
    Lazareva, O. V.
    Bykova, A. V.
    Tkhai, N. V.
    Khoroshko, N. D.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2012, 57 (04): : 3 - 11
12345